AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture cadillacnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cadillacnews.com Daily Mail and Mail on Sunday newspapers.
Fiscal Year 2024 Second Quarter Highlights
Net sales of $79.1 million increased 2.7% on a pro-forma basis compared to the prior-year quarter
Med Tech net sales of $25.4 million increased.
Fiscal Year 2024 First Quarter Highlights
Net sales of $78.7 million as reported
Includes $0.7 million of Dialysis and BioSentry Biopsy Tract Sealant System sales
Net sales increased 5.7%.